logo
Select company
Select metric
-154.69%Operating Cash Flow Margin
VS
Market
10
Sector
34
Industry
62
History
15
$ 1.23Close
$ 0.47 - $ 4.22 52-Week Range
Ticker Information

Ticker

NBY

Company Name

NOVABAY PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

NOVABAY PHARMACEUTICALS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NBY - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -7.35M-154.69%$ 4.75M
3/31/2025$ -4.93M-69.02%$ 7.15M
12/31/2024$ -5.18M-52.99%$ 9.78M
9/30/2024$ -4.53M-40.41%$ 11.2M
6/30/2024$ -2.83M-23.51%$ 12.02M
3/31/2024$ -4.09M-28.75%$ 14.23M
12/31/2023$ -4.13M-28.05%$ 14.73M
9/30/2023$ -5.03M-34.33%$ 14.64M
6/30/2023$ -6.35M-41.78%$ 15.2M
3/31/2023$ -6.21M-45.52%$ 13.64M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NOVABAY PHARMACEUTICALS INC's latest trailing twelve months (TTM) OCF % stands at -48.26%.
  • Over the past 5 years, NOVABAY PHARMACEUTICALS INC's average OCF % has been -63.23%.
  • The median OCF % for NOVABAY PHARMACEUTICALS INC during this period was -50.62%
  • NOVABAY PHARMACEUTICALS INC reached its highest OCF % over the past 5 years at -23.51%.
  • The lowest OCF % recorded by NOVABAY PHARMACEUTICALS INC in the same timeframe -154.69%

NOVABAY PHARMACEUTICALS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
INM : INMED PHARMACEUTICALS INC -157.14%XBIO : XENETIC BIOSCIENCES INC -102.96%CNSP : CNS PHARMACEUTICALS INC -ENVB : ENVERIC BIOSCIENCES INC -CPHI : CHINA PHARMA HOLDINGS INC 9.66%GRI : GRI BIO INC -AZTR : AZITRA INC -ONCO : ONCONETIX INC -412.54%SPRB : SPRUCE BIOSCIENCES INC -3961.12%REVB : REVELATION BIOSCIENCES INC -

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for NOVABAY PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ -4.71M ] / Revenues [ $ 9.75M ]
(=) OCF % [ -48.26% ]

NBY - Operating Cash Flow Margin, Last 5 years

-154.69%

Minimum

Jun 30, 2025

-23.51%

Maximum

Jun 30, 2024

-63.23%

Average

-50.62%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.35% with a standard deviation of 21.14%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max78.12%
average14.35%
median12.67%
std21.14%